156
0 Kommentare
Menarini Ricerche Announces SEL24/MEN1703 Pharmacodynamic Data from the Dose Escalation Part of DIAMOND-01 Trial - Seite 3
The Menarini Group is a leading international pharmaceutical and diagnostics company, with a turnover of €3.793 billion and over 17,000 employees. Menarini is focused on therapeutic areas with high unmet needs with products for cardiology, gastroenterology, pneumology, infectious diseases, diabetology, inflammation, and analgesia. With 17 production sites and 10 Research and Development centers, Menarini's products are available in 140 countries worldwide. For further information, please visit www.menarini.com
Lesen Sie auch
Logo: https://mma.prnewswire.com/media/1345630/DIAMOND_1_Logo.jpg
Logo: http://mma.prnewswire.com/media/520214/Menarini_Ricerche_Logo.jpg
Aktuelle Themen
Weitere Artikel des Autors
Verfasst von PR Newswire (engl.)